prime peptides semaglutide FDA warns companies over unapproved weight loss drug sales GLP-1 for Weight Loss: How

This single-pathway mechanism has been extensively studied in millions of patients and consistently produces weight loss of 1522% of body weight over 68 weeks in clinical trials

It can increase your risk of kidney injury or worse

It is important to note that SOUL was designed as a CV safety and efficacy trial, not a dedicated kidney outcomes trial

Elmiron, a drug prescribed for interstitial cystitis, has been linked to serious eye damage and vision problems in scientific studies

July 6, 2026 STAT+: Online GLP-1 prescriptions are often fast, easy and low on clinical oversight This article from STAT News covers: STAT+: Online GLP-1 prescriptions are often fast, easy and low on clinical oversight